Impact of the 8-week Administration of Tofogliflozin for Glycemic Control and Body Composition in Japanese Patients with Type 2 Diabetes Mellitus
about
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trialWhy do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis.Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes.Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus.
P2860
Impact of the 8-week Administration of Tofogliflozin for Glycemic Control and Body Composition in Japanese Patients with Type 2 Diabetes Mellitus
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Impact of the 8-week Administr ...... with Type 2 Diabetes Mellitus
@en
Impact of the 8-week Administr ...... with Type 2 Diabetes Mellitus.
@nl
type
label
Impact of the 8-week Administr ...... with Type 2 Diabetes Mellitus
@en
Impact of the 8-week Administr ...... with Type 2 Diabetes Mellitus.
@nl
prefLabel
Impact of the 8-week Administr ...... with Type 2 Diabetes Mellitus
@en
Impact of the 8-week Administr ...... with Type 2 Diabetes Mellitus.
@nl
P2093
P2860
P1433
P1476
Impact of the 8-week Administr ...... with Type 2 Diabetes Mellitus
@en
P2093
Sachie Hirose
Shinsuke Nakajima
Tetsuya Takahashi
Yasuyuki Iwahashi
Yoshikazu Tamori
P2860
P304
P356
10.2169/INTERNALMEDICINE.55.6367
P577
2016-11-15T00:00:00Z